Health Catalyst, Inc. (HCAT) Return on equity 2019–2025
Health Catalyst, Inc. (HCAT) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-72.4%FY2025 · since FY2019: -30.0% → -72.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -72.4% | -53.4 pp |
| FY2024 | -19.0% | +13.2 pp |
| FY2023 | -32.2% | +0.1 pp |
| FY2022 | -32.3% | -3.0 pp |
| FY2021 | -29.3% | +12.3 pp |
| FY2020 | -41.7% | -11.7 pp |
| FY2019 | -30.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More HCAT financial trends
HCAT RevenueHCAT Net incomeHCAT Net marginHCAT Gross profitHCAT Gross marginHCAT Operating incomeHCAT Operating marginHCAT Operating cash flowHCAT Free cash flowHCAT Capital expendituresHCAT Stock buybacksHCAT Dividends paidHCAT Total assetsHCAT Total liabilitiesHCAT Shareholders’ equityHCAT overview →